desire

Flibanserin (Girosa) is a serotonergic antidepressant used to treat hypoactive sexual desire disorder. Flibanserin has been associated with a low rate of minor serum aminotransferase elevations during treatment but has not been linked to instances of clinically apparent acute liver injury.

Pinolenic acid is a polyunsaturated fatty acid found in Korean pine (Pinus orientalis) and maritime pine (Pinus pinaster) seed oils, which exhibit lipid-lowering properties. In transgenic mice expressing human ApoA1, a diet containing maritime pine seed oil (MPSO) reduced high-density lipoprotein and ApoA1 levels and diminished cholesterol efflux in vitro. Korean pine seed oil supplements may aid in reducing obesity by decreasing appetite, as evidenced by increased levels of satiety hormones CCK and GLP-1 and reduced desire to eat. Pinolenic acid, which is not metabolically converted to arachidonic acid, can lower arachidonic acid levels in the phosphatidylinositol fraction of HepG2 cells from 15.9% to 7.0%. The neutral, more lipophilic form of pinolenic acid is pinolenic acid ethyl ester.

Flibanserin (BIMT-17; BIMT-17BS) hydrochloride is an orally active compound that functions as a 5-HT1A receptor agonist (Ki: 1 nM) and a 5-HT2A receptor antagonist (Ki: 49 nM) of 5-hydroxytryptamine. It possesses antidepressant and anxiolytic effects and is used in studies of hypoactive sexual desire (HSDD).

Orenetide is an innovative peptide-based pharmaceutical designed to rejuvenate sexual desire and associated functions in women suffering from hypoactive sexual desire disorder (HSDD) [1].

Flibanserin-d4-1 is the deuterated form of Flibanserin. Flibanserin (BIMT-17) functions as a full agonist at the 5-hydroxytryptamine (5-HT1A) receptor with a Ki of 1 nM, and as an antagonist at the 5-HT2A receptor with a Ki of 49 nM. It binds to dopamine D4 receptors with an affinity ranging from 4 to 24 nM, while showing negligible affinity for various other neurotransmitter receptors and ion channels. Flibanserin is being investigated for its potential in treating hypoactive sexual desire disorder (HSDD).